230 related articles for article (PubMed ID: 30019681)
1. 'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma.
Rutten KHG; Raymakers RAP; Minnema MC
Neth J Med; 2018 Jul; 76(5):249-250. PubMed ID: 30019681
[TBL] [Abstract][Full Text] [Related]
2. Dysphagia unveiling systemic immunoglobulin light-chain amyloidosis with multiple myeloma.
Gonzalez J; Wahab A; Kesari K
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30344148
[TBL] [Abstract][Full Text] [Related]
3. A dangerous onychodystrophy.
Martinelli N; Olivieri O
Am J Hematol; 2021 Jul; 96(7):891-892. PubMed ID: 33180338
[No Abstract] [Full Text] [Related]
4. An interesting case of AL amyloidosis and MM: a complex scenario with cardiac involvement.
Gaba M; Kumar N; Pandey A; Dewan A
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272507
[TBL] [Abstract][Full Text] [Related]
5. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
[TBL] [Abstract][Full Text] [Related]
6. Classic features of primary systemic amyloidosis (AL amyloidosis) leading to diagnosis of plasma cell myeloma.
Tan KW; Zhu B; Behrens E; Tarbox MB
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738847
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
Andrei M; Wang JC
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
[TBL] [Abstract][Full Text] [Related]
8. Role of oral examination in newly diagnosed multiple myeloma patients: A safe and simple way to detect light chain amyloidosis.
Leiba M; Jarjoura S; Abboud W; Nagler A; Yahalom R; Duek A; Yarom N
Oral Dis; 2018 Oct; 24(7):1343-1348. PubMed ID: 29791070
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
[TBL] [Abstract][Full Text] [Related]
10. Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.
Kourelis TV; Kumar SK; Gertz MA; Lacy MQ; Buadi FK; Hayman SR; Zeldenrust S; Leung N; Kyle RA; Russell S; Dingli D; Lust JA; Lin Y; Kapoor P; Rajkumar SV; McCurdy A; Dispenzieri A
J Clin Oncol; 2013 Dec; 31(34):4319-24. PubMed ID: 24145344
[TBL] [Abstract][Full Text] [Related]
11. Laryngotracheal Involvement in Systemic Light Chain Amyloidosis.
Ginat DT; Schulte J; Portugal L; Cipriani NA
Head Neck Pathol; 2018 Mar; 12(1):127-130. PubMed ID: 28616786
[TBL] [Abstract][Full Text] [Related]
12. Multiple Myeloma Light Chain Amyloidosis Presenting as Hepatic Failure.
Elgouhari H; Ahmed K; Niazi M; Huntington MK
S D Med; 2018 Mar; 71(3):112-115. PubMed ID: 29991097
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.
Kobayashi H; Abe Y; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
Jpn J Clin Oncol; 2019 Feb; 49(2):195-198. PubMed ID: 30608548
[TBL] [Abstract][Full Text] [Related]
14. Case records of the Massachusetts General Hospital: Case 29-2011: A 66-year-old woman with cardiac and renal failure.
Raje NS; Steele DJ; Lawrimore TM; Johri AM; Sohani AR
N Engl J Med; 2011 Sep; 365(12):1129-38. PubMed ID: 21992126
[No Abstract] [Full Text] [Related]
15. Intraoral manifestation of systemic AL amyloidosis with unique microscopic presentation of intracellular amyloid deposition in striated muscles.
Oruba Z; Kaczmarzyk T; Urbańczyk K; Jurczyszyn A; Fornagiel S; Gałązka K; Bednarczyk A; Chomyszyn-Gajewska M
Pol J Pathol; 2018; 69(2):200-204. PubMed ID: 30351869
[TBL] [Abstract][Full Text] [Related]
16. AL Amyloidosis in Myeloma: Red Flag Symptoms.
Mendelson L; Shelton A; Brauneis D; Sanchorawala V
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):777-778. PubMed ID: 32631780
[No Abstract] [Full Text] [Related]
17. AL amyloidosis presenting with limb girdle myopathy.
Malek N; O'Donovan DG; Manji H
Pract Neurol; 2018 Dec; 18(6):497-500. PubMed ID: 30042220
[TBL] [Abstract][Full Text] [Related]
18. Systemic AL amyloidosis associated with multiple myeloma in a horse.
Kim DY; Taylor HW; Eades SC; Cho DY
Vet Pathol; 2005 Jan; 42(1):81-4. PubMed ID: 15657277
[TBL] [Abstract][Full Text] [Related]
19. Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein.
Ishiguro K; Hayashi T; Yokoyama Y; Aoki Y; Onodera K; Ikeda H; Ishida T; Nakase H
Intern Med; 2018 Mar; 57(6):783-788. PubMed ID: 29021469
[TBL] [Abstract][Full Text] [Related]
20. [Specific cytoplasmic crystalline inclusions in multiple myeloma with amyloidosis].
Nomura N; Uchida H; Roppongi H; Tonozuka N; Shirota T; Sakai N; Ito H; Toyoda M; Ebihara Y
Rinsho Ketsueki; 1989 Nov; 30(11):2002-7. PubMed ID: 2558235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
